Private company

Imricor Medical Systems, Inc.

American surgical and medical instruments and apparatus company based in Dover2

In its 2026 registration with the SEC (Form 10) the company says: “Imricor Medical Systems, Inc. is a medical technology company pioneering the development and commercialization of magnetic resonance imaging-compatible interventional products for cardiac ablation and other procedures.”13

Last updated Oct 20, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus2
  • HeadquartersDover, United States2
  • Incorporated inDE3
  • Business address400 Gateway Blvd., Burnsville, Mn 553373
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3
  • Legal formCorporation2
  • LEI529900B6K3965WTT4E522
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressc/o COGENCY GLOBAL INC., 850 NEW BURTON ROAD SUITE 201, 19904 Dover, United States2
  • Registered withDivision of Corporations, Department of State, 41626032

Corporate structure

Imricor Medical Systems, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Imricor Medical Systems, Inc.

  • K.A.H.R. FOUNDATION Filed SCHEDULE 13G on Imricor Medical Systems, Inc., latest May 20, 2026
  • Imricor Medical Systems, Inc. Dover, Delaware, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Who has led Imricor Medical Systems, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (6)

Timeline

  1. May 18, 2026New chief executive Steven Robert Wedan becomes CEO4
  2. May 22, 2006Founded Imricor Medical Systems, Inc. is founded2

Filings

13 filings to the SEC since October 2021: 1 quarterly reports, 7 insider forms, 1 large holders, 4 other. The latest 13:

  1. Aug 7, 202610-Q EDGAR
  2. Jun 25, 2026S-8 EDGAR
  3. May 20, 2026SCHEDULE 13G EDGAR
  4. May 19, 20263 PRIMARY DOCUMENT EDGAR
  5. May 18, 20263 PRIMARY DOCUMENT EDGAR
  6. May 18, 20263 PRIMARY DOCUMENT EDGAR
  7. May 18, 20263 PRIMARY DOCUMENT EDGAR
  8. May 18, 20263 PRIMARY DOCUMENT EDGAR
  9. May 18, 20263 PRIMARY DOCUMENT EDGAR
  10. May 18, 20263 PRIMARY DOCUMENT EDGAR
  11. May 15, 202610-12G/A EDGAR
  12. Apr 24, 202610-12G/A EDGAR
  13. Mar 18, 202610-12G EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Imricor Medical Systems, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARImricor Medical Systems, Inc.1
  • CIK0002121708
  • Employer ID (EIN)20-49144801
  • Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address400 Gateway Blvd., Burnsville, MN 553371
  • Phone(952) 818-84001
  • Shares outstanding358,572,497 as of Aug 7, 202612
  • On EDGAR sinceMar 18, 20261
  • Filings13 in all: 3 (7), 10-12G/A (2), 10-12G (1), 10-Q (1), S-8 (1), SCHEDULE 13G (1)1
  • Latest filingsQuarterly report (10-Q) Aug 7, 2026